AnalystsCory KasimovCory Kasimov's Stock Forecasts
AnalystsCory Kasimov
Analyst Ranking
Top 14%
#780 out of 5511 analysts
Average Return
+15%
Win Rate
54%37 out of 68
Risk vs Reward
Poor
Good
Cory Kasimov's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Bluebird Bio IncBLUE | +369.12% | $733.20 | $3,439.60 | 2014-06-18 - 2015-06-18 | Strong Buy |
Bridgebio Pharma IncBBIO | +177.60% | $27.77 | $77.09 | 2024-12-23 - 2025-12-22 | Buy |
Immunome IncIMNM | +176.89% | $10.30 | $28.52 | 2025-08-22 - 2026-08-21 | Buy |
Vir Biotechnology IncVIR | +108.71% | $5.51 | $11.50 | 2025-09-03 - 2026-09-02 | Buy |
Gilead Sciences IncGILD | +90.55% | $32.90 | $62.69 | 2012-09-17 - 2013-09-17 | Strong Buy |
Cory Kasimov Analyst Color
Get additional color on Cory Kasimov's coverage of popular stocks
Cory Kasimov's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Scholar Rock Holding CorpSRRK | 1 | Buy | $72.00 | +44.00% | Maintains | a day ago |
Revolution Medicines IncRVMD | 4 | Buy | $320.00 | +56.20% | Maintains | 20 days ago |
Biontech SeBNTX | 4 | Buy | $130.00 | +34.45% | Maintains | a month ago |
Edgewise Therapeutics IncEWTX | 4 | Buy | $55.00 | +26.06% | Maintains | 2 months ago |
Hemab Therapeutics Holdings IncCOAG | 1 | Buy | $50.00 | +24.66% | Initiates Coverage On | 4 months ago |
Benitec Biopharma IncBNTC | 1 | Buy | $25.00 | +126.24% | Initiates Coverage On | 4 months ago |
Bridgebio Pharma IncBBIO | 5 | Buy | $130.00 | +90.09% | Maintains | 4 months ago |
Biomarin Pharmaceutical IncBMRN | 5 | Buy | $120.00 | +86.19% | Maintains | 4 months ago |
Moderna IncMRNA | 7 | Hold | $50.00 | -65.22% | Maintains | 4 months ago |
Upstream Bio IncUPB | 2 | Hold | $15.00 | +173.72% | Downgrades | 6 months ago |
Arcellx IncACLX | 2 | Hold | $115.00 | -0.06% | Downgrades | 7 months ago |
Vir Biotechnology IncVIR | 2 | Buy | $18.00 | +72.41% | Maintains | 7 months ago |
Regeneron Pharmaceuticals IncREGN | 5 | Buy | $875.00 | +13.03% | Maintains | 8 months ago |
Immunome IncIMNM | 2 | Buy | $40.00 | +67.01% | Maintains | 9 months ago |
Zenas Biopharma IncZBIO | 1 | Buy | $55.00 | +72.25% | Initiates Coverage On | 10 months ago |
Beam Therapeutics IncBEAM | 1 | Buy | $35.00 | +50.73% | Initiates Coverage On | 10 months ago |
Oric Pharmaceuticals IncORIC | 1 | Buy | $25.00 | +102.27% | Initiates Coverage On | 10 months ago |
Cytokinetics IncCYTK | 1 | Buy | $80.00 | N/A | Maintains | a year ago |
Summit Therapeutics IncSMMT | 2 | Buy | $34.00 | N/A | Maintains | a year ago |
Xenon Pharmaceuticals IncXENE | 1 | Buy | $55.00 | N/A | Initiates Coverage On | a year ago |
Neurocrine Biosciences IncNBIX | 2 | Buy | $185.00 | N/A | Maintains | a year ago |
Springworks Therapeutics IncSWTX | 2 | Buy | $65.00 | N/A | Maintains | 2 years ago |
Ultragenyx Pharmaceutical IncRARE | 3 | Strong Buy | $88.00 | N/A | Maintains | 3 years ago |
Karuna Therapeutics IncKRTX | 2 | Strong Buy | $250.00 | N/A | Maintains | 3 years ago |
Cerevel Therapeutics Holdings IncCERE | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 5 years ago |
Biogen IncBIIB | 2 | Hold | $276.00 | N/A | Maintains | 5 years ago |
Sana Biotechnology IncSANA | 1 | Hold | $35.00 | N/A | Initiates Coverage On | 6 years ago |
Bluebird Bio IncBLUE | 5 | Hold | $780.00 | N/A | Downgrades | 6 years ago |
Incyte CorpINCY | 2 | Hold | N/A | N/A | Downgrades | 6 years ago |
Gilead Sciences IncGILD | 2 | Hold | N/A | N/A | Downgrades | 6 years ago |
Alexion Pharmaceuticals IncALXN | 1 | Strong Buy | $163.00 | N/A | Maintains | 6 years ago |
Alkermes PLCALKS | 2 | Hold | $21.00 | N/A | Downgrades | 7 years ago |
Jounce Therapeutics IncJNCE | 4 | Strong Sell | N/A | N/A | Downgrades | 8 years ago |
Puma Biotechnology IncPBYI | 4 | Strong Sell | $23.00 | N/A | Maintains | 8 years ago |
Clovis Oncology IncCLVSQ | 5 | Hold | $16.00 | N/A | Downgrades | 8 years ago |
Amgen IncAMGN | 2 | Hold | $192.00 | N/A | Maintains | 8 years ago |
Spark Therapeutics IncONCE | 3 | Hold | $63.00 | N/A | Maintains | 8 years ago |
Celgene CorpCELG | 1 | Strong Buy | $110.00 | N/A | Reinstates | 8 years ago |
Lexicon Pharmaceuticals IncLXRX | 1 | Strong Sell | $10.00 | N/A | Maintains | 9 years ago |
Dynavax Technologies CorpDVAX | 1 | Hold | $250.00 | N/A | Maintains | 9 years ago |
Ethos Technologies IncLIFE | 1 | Strong Sell | N/A | N/A | Downgrades | 9 years ago |
Atyr Pharma IncATYR | 2 | Strong Buy | $140.00 | N/A | Maintains | 10 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.